Summer Special! Get NewsNow Essentials at just £2.99 a month (25% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £2.99 a month (25% OFF!). Subscribe and saveSummer Special! Upgrade here at £2.99/m (25% OFF!)

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
Tech
Science

Teva
Pharmaceuticals
AstraZeneca
Novo Nordisk
Eli Lilly
Sanofi
Pfizer
GSK
Johnson & Johnson
Topics

Advertisement

Teva

Share

Top Latest Popular

In the last 6 hours

Teva’s New Trailpeak Is Its Most Lightweight Trail Runner to Date Gear Patrol 20:43 Fri, 07 Aug

Yesterday

Teva Pharmaceutical Industries (TEVA) Lifts Outlook On Earnings As Valuation Debate Stays Open Simply Wall St 16:50 Fri, 07 Aug

Citing Gaza war, pharma firm Teva seeks to keep its Israeli origins from US jury The Times of Israel 12:00 Fri, 07 Aug

Advertisement

Advertisement

Thursday

The Dpa That Didn’t Go Away: Court Grants Summary Judgment Based on Admissions Made in Criminal Deferred Prosecution Agreement National Law Review 22:46 Thu, 06 Aug

Judge OKs $35M Teva Deal In Delayed Generic Inhalers Suit Law360 17:37 Thu, 06 Aug

Monday

Teva Beats UnitedHealth’s RICO Claim for Copaxone Charity Copays Bloomberg Law 16:03 Mon, 03 Aug

Sunday

Why Teva Pharmaceutical Stock Surged This Week The Motley Fool 17:53 Sun, 02 Aug

Dear Teva Pharmaceutical Stock Fans, Mark Your Calendars for September 14 Barchart 15:18 Sun, 02 Aug

In the last month

Teva Q2 Earnings Lag Estimates, 2026 Revenue View Raised, Stock Rises Zacks 18:31 Thu, 30 Jul

Teva’s $40 billion comeback brings Wall Street’s biggest prize into view CTech 10:45 Thu, 30 Jul

Teva's Innovative Drug Portfolio Fuels Growth as Company Raises Outlook, Transitions to Direct NYSE Listing Benzinga 19:04 Wed, 29 Jul

Branded drugs boost Teva revenue Globes 13:15 Wed, 29 Jul

Teva Pharmaceutical Slips To Loss In Q2, Raises FY26 Revenue Outlook; Stock Up In Pre-Market RTT News 12:49 Wed, 29 Jul

Advertisement

Uzedy®: Record Q2 Net Sales of $77M, Up 43% YoY; Teva Raises 2026 Outlook Business Wire (Press Release) 12:46 Wed, 29 Jul

Teva posts strong revenue growth as branded drugs surpass $1 billion, despite acquisition-driven loss CTech 12:43 Wed, 29 Jul

Medincell: Uzedy®: Record Q2 Net Sales of $77M, Up 43% YoY; Teva Raises 2026 Outlook Business Wire (Press Release) 12:25 Wed, 29 Jul

‘It is okay not to be okay’: NFL legend Terrell Davis joins growing roster of athletes partnering with big pharma to raise health awareness Fortune 09:16 Wed, 29 Jul

Teva Can't 'Literally Whine' Of Being Held To DOJ Admissions Law360 21:17 Tue, 28 Jul

Stay Ahead of the Game With Teva Pharmaceutical Industries (TEVA) Q2 Earnings: Wall Street's Insights on Key Metrics Zacks 15:21 Tue, 28 Jul

Should Teva’s Branded-Drug Pivot and Duvakitug Bet Reshape How TEVA Investors View Earnings Power? Simply Wall St 00:16 Tue, 28 Jul

Teva and Samsung Bioepis Enter Into Commercialization Agreement for OPUVIZ in Canada JD Supra 17:38 Mon, 27 Jul

Teva Revives an Archival Favorite with Premium Materials and Modern Style Gear Patrol 15:11 Mon, 27 Jul

Teva's Turnaround Is Working. Here's the 1 Thing That Could Send It Soaring Another 50%. The Motley Fool 20:01 Sun, 26 Jul

Wall Street Thinks Teva Can Soar Over 60%. Here's Why Analysts Are Right. The Motley Fool 14:55 Sun, 26 Jul

Deckers sales rise as HOKA and international markets drive growth The Industry London 13:09 Fri, 24 Jul

Composition or Method? How Amgen and Teva Are Reshaping Drug Patent Strategy JD Supra 17:11 Wed, 22 Jul

Noteworthy ETF Outflows: EFA, SPOT, NBIS, TEVA Nasdaq 16:09 Tue, 21 Jul

Practical Guidance for Pharmaceutical Method-of-Use Patent Claims After Teva v. Eli Lilly and In re Xencor National Law Review 17:25 Mon, 20 Jul

Teva stock’s downward trend continues Globes 13:05 Sun, 19 Jul

Other Barks & Bites for Friday, July 17: CJEU Says Commercial Partnership May Make Google Liable for Gambling Ads; CAFC Corrects CFC on Book of Wisdom; Tillis Indicates PERA Tweaks IPWatchdog.com 20:48 Fri, 17 Jul

Teva and Polpharma Biologics Announce Global Licensing Agreement for Ocrelizumab Biosimilar for Multiple Sclerosis JD Supra 17:45 Thu, 16 Jul

Pharmaceutical Method-of-Use Claims After Teva v. Eli Lilly and In re Xencor: Written Description, Enablement, and the Known-Compound Genus National Law Review 21:41 Wed, 15 Jul

Teva Celebrates the Pursuit of Adventure with New Performance and Lifestyle Footwear from its Fall 2026 Collection Business Wire (Press Release) 14:01 Wed, 15 Jul

Teva’s beef with Lilly over Forteo settlement lives again BioWorld 22:08 Tue, 14 Jul

STAT Plus: Pharmalittle: We’re reading about a battle between Lilly and Teva, psychedelic drugs, and more STAT 14:23 Tue, 14 Jul

7th Circ. Revives Teva Suit Over Eli Lilly Generic Drug Block Law360 23:16 Mon, 13 Jul

Federal Circuit Finds Method-of-Treatment Claims Including In Vivo Dosing Limitations Are Not Enabled By In Vitro Data National Law Review 20:28 Mon, 13 Jul

Teva Revives Lilly Contract Suit Over Copy of Bone-Loss Drug Bloomberg Law 20:20 Mon, 13 Jul

Fed. Circ. Won't Rethink Corcept Patent Loss In Teva Case Law360 23:15 Fri, 10 Jul

Celltrion and Teva’s TRUXIMA® Becomes First Interchangeable Rituximab Biosimilar in U.S. JD Supra 17:14 Fri, 10 Jul

Advertisement

Advertisement

Teva News

NewsNow brings you the latest news from the world’s most trusted sources on Teva. NewsNow aims to be the world’s most accurate and comprehensive Teva news aggregator, bringing you the latest headlines automatically and continuously 24/7.

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis